Literature DB >> 11110715

Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.

M Cazzola1, A May, G Bergamaschi, P Cerani, V Rosti, D F Bishop.   

Abstract

X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinic acid synthase (ALAS2) gene. An elderly woman who presented with an acquired sideroblastic anemia is studied. Molecular analysis revealed that she was heterozygous for a missense mutation in the ALAS2 gene, but she expressed only the mutated gene in reticulocytes. Her 2 daughters and a granddaughter were heterozygous for this mutation, had normal hemoglobin levels, and expressed the normal ALAS2 gene in reticulocytes. A grandson with a previous diagnosis of thalassemia intermedia was found to be hemizygous for the ALAS2 mutation. Treatment with pyridoxine completely corrected the anemia both in the proband and her grandson. All women who were analyzed in this family showed skewed X-chromosome inactivation in leukocytes, which indicated a hereditary condition associated with unbalanced lyonization. Because the preferentially active X chromosome carried the mutant ALAS2 allele, acquired skewing in the elderly likely worsened the genetic condition and abolished the normal ALAS2 allele expression in the proband. (Blood. 2000;96:4363-4365)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110715

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Skewed X inactivation and survival: a 13-year follow-up study of elderly twins and singletons.

Authors:  Jonas Mengel-From; Mikael Thinggaard; Lene Christiansen; James W Vaupel; Karen Helene Orstavik; Kaare Christensen
Journal:  Eur J Hum Genet       Date:  2011-12-07       Impact factor: 4.246

2.  No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans.

Authors:  Véronique Bolduc; Pierre Chagnon; Sylvie Provost; Marie-Pierre Dubé; Claude Belisle; Marianne Gingras; Luigina Mollica; Lambert Busque
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 3.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

4.  Ring sideroblasts and sideroblastic anemias.

Authors:  Mario Cazzola; Rosangela Invernizzi
Journal:  Haematologica       Date:  2011-06       Impact factor: 9.941

Review 5.  Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.

Authors:  Kazumichi Furuyama; Kiriko Kaneko
Journal:  Int J Hematol       Date:  2017-11-14       Impact factor: 2.490

6.  X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation.

Authors:  Vijay G Sankaran; Jacob C Ulirsch; Vassili Tchaikovskii; Leif S Ludwig; Aoi Wakabayashi; Senkottuvelan Kadirvel; R Coleman Lindsley; Rafael Bejar; Jiahai Shi; Scott B Lovitch; David F Bishop; David P Steensma
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

7.  Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis C infection. A case report.

Authors:  Pauline Lee; Lawrence Rice; John J McCarthy; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2008-09-26       Impact factor: 3.039

Review 8.  Erythroid heme biosynthesis and its disorders.

Authors:  Harry A Dailey; Peter N Meissner
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

9.  A novel hemizygous I418S mutation in the ALAS2 gene in a young Korean man with X-linked sideroblastic anemia.

Authors:  Soo Young Moon; In-Jae Jun; Ji-Eun Kim; Seung Jun Lee; Hyun Kyung Kim; Sung-Soo Yoon
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

10.  Analysis of X chromosome inactivation in autism spectrum disorders.

Authors:  Xiaohong Gong; Elena Bacchelli; Francesca Blasi; Claudio Toma; Catalina Betancur; Pauline Chaste; Richard Delorme; Christelle M Durand; Fabien Fauchereau; Hany Goubran Botros; Marion Leboyer; Marie-Christine Mouren-Simeoni; Gudrun Nygren; Henrik Anckarsäter; Maria Rastam; I Carina Gillberg; Christopher Gillberg; Daniel Moreno-De-Luca; Simona Carone; Ilona Nummela; Mari Rossi; Agatino Battaglia; Irma Jarvela; Elena Maestrini; Thomas Bourgeron
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.